- Oral NSAIDs are commonly used for relieving pain, reducing inflammation, and managing fever in conditions such as arthritis, musculoskeletal injuries, and menstrual cramps
- The market is primarily driven by the increasing prevalence of chronic pain disorders, growing geriatric population, and rising demand for non-opioid pain management alternatives
- North America is expected to dominate the oral nonsteroidal anti-inflammatory drugs market due to advanced healthcare infrastructure, high awareness about pain management, and strong presence of pharmaceutical companies
- Asia-Pacific is expected to be the fastest growing region in the oral nonsteroidal anti-inflammatory drugs market during the forecast period due to increasing healthcare access, expanding middle-class population, and rising incidence of chronic conditions
- The arthritis segment is expected to dominate the market with a market share of 38.5%, attributed to high global prevalence of osteoarthritis and rheumatoid arthritis, particularly among the aging population
